"Winter Disease and Summer Treatment" at that time
Release time:
2020-08-14
"Winter Disease and Summer Treatment" is in midsummer at the time of
. Many people are busy doing "three-volt moxibustion" to prepare for winter health care. Although the materials used in "Sanfu Moxibustion" are only ordinary ginger and moxa sticks, they are actually using summer, the most vigorous period of yang in nature, to allow the human body to replenish qi and warm yang, dispel cold and clear collaterals, thereby reducing deficiency and cold diseases. The probability of onset. This is "winter disease and summer treatment", a dialectical concept of traditional Chinese medicine, with the help of the trend of heaven and earth, to prevent seasonal diseases at the most economical cost.
The idea of "treating winter diseases in summer" can not only be used to regulate the body, but also for enterprise management. To put it another way, it is to think more about future difficulties when things are going well, to prevent possible falls during the rising period, to prepare for the upcoming "winter" in the prosperous "summer", to be prepared for danger in times of peace, and to take precautions.
Looking back on the development of the peak, it is undoubtedly the best period-operating income and profits are rising year by year, the stock price is strong against the market, and the first half of this year has created the best performance ever, which is gratifying enough. However, at the work analysis meeting in the first half of the year held not long ago, General Manager Yu Jianhong pointed out with great concern that most of the current benefit growth comes from the favorable market environment, and the endogenous growth capacity of enterprises is seriously insufficient. compared with the advanced enterprises of the same industry, there is an obvious gap in many aspects, and if the market situation is turbulent, it is likely to face a huge business crisis.
The general manager's analysis is by no means alarmist. The national economy and enterprise development have cyclical changes, and ups and downs are the real normal. For example, due to the promotion of "Belt and Road Initiative" and the increase of investment in infrastructure construction in Yunnan, the cement market is improving, and the peak benefit of Yunnan has doubled compared with the same period last year, but how many years can this benefit last? If you want to continue to "lead" after the foreseeable market decline in the future, you can only start from yourself, through technological transformation, management upgrades, and cost reduction, and enhance the comparative advantage with peers. Even so, whether you can achieve the current profit scale It is still unknown. Compared with the cement industry with strong regional effects, the medical and health industry has to face a multi-variety, multi-regional, and multi-standard market. The situation is more complicated. Once the environment changes, the pressure on enterprises can be imagined.
Innovation is the only way to enhance strength and lasting development. To this end, Chairman Jiang Xiaomeng proposed at the work analysis meeting in the first half of the year that efforts should be made to achieve the "five breakthroughs." the most fundamental thing is the breakthrough in people's thinking and concepts. Objectively speaking, the good operation of enterprises for many years has made many peak people complacent and slack off; others are only satisfied with their own year-on-year progress, but forget to look at the outside world more. The glittering report card has weakened our sense of crisis and slowed our progress. But the face is bright, if the lining can't keep up, when the "cold winter" comes, do we have enough "yang" to "keep out the cold"?
Recuperate your body as early as possible. The current peak has an incomparable good situation in the past. The internal capital, manpower and material resources are abundant, and the external policies and market are favorable, which give us the best time to adjust. At this time to seek "change", we can afford the cost, pay the time, even not afraid of trial and error, not afraid of detours. However, if we do this when we have to "change", it is more likely that we will fall into a deadlock that is difficult to take care of at the beginning and end, and we want to "change" but cannot. Therefore, taking advantage of this opportunity of "sufficient yang", our managers might as well take a serious look at themselves, come back to the enterprise version of "winter disease and summer treatment" in a down-to-earth manner, grasp the fundamentals to strengthen their health, and make themselves more powerful to resist the "cold winter" in the future ". (Hong Tao)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11